Skip to main content
Clinical Trials/NCT01573390
NCT01573390WithdrawnNot Applicable

Non Invasive and Non-Contact Dual-modal Imaging Of Tissue Oxygenation and Vascular Reactivity Dynamic Imaging Of Tissue Metabolism and Vascular Function.

Chandan K Sen1 site in 1 countryStarted: April 9, 2012Last updated:
Conditions

Trial Snapshot

Phase
Not Applicable
Status
Withdrawn
Sponsor
Locations
1
Primary Endpoint
Non-Contact Oxygenation Imagiing

Study Overview

Brief Summary

  1. Quantitative validation of non-contact oxygenation imaging by the CWC imaging system
  2. Quantitative validation of non-contact vascular function imaging by the CWC imaging system
  3. Evaluation of the clinical usability of the CWC imaging system for further technology development and engineering improvement

Detailed Description

The hyperspectral imaging technique estimates cutaneous tissue oxygenation by illuminating tissue and detecting tissue reflectance at different wavelengths. One major advantage of hyperspectral imaging is non-invasive and non-contact detection of tissue functional properties. The dual-mode imaging system integrates hyperspectral and thermal imaging modalities for simultaneous assessment of cutaneous tissue oxygenation and vascular function. This clinical protocol is defined to validate the CWC system on healthy human subjects

Study Design

Study Type
Observational
Observational Model
Other
Time Perspective
Prospective

Eligibility Criteria

Ages
18 Years to — (Adult, Older Adult)
Sex
All
Accepts Healthy Volunteers
Yes

Inclusion Criteria

  • Adult 18 years and older
  • No history of diabetes.
  • No history of vascular disease

Exclusion Criteria

  • Under 18 years of age
  • Unable to provide informed consent
  • Prisoners
  • Current smoker

Outcomes

Primary Outcomes

Non-Contact Oxygenation Imagiing

Time Frame: 1 year

Quantitative validation of non-contact oxygenation imaging by the CWC imaging system

Non-Contact Vascular Function Imaging

Time Frame: 1 year

Quantitative validation of non-contact vascular function imaging by the CWC imaging system

Secondary Outcomes

  • Clinical usability for Comprehensive Wound Centers(1 year)

Investigators

Sponsor
Chandan K Sen
Sponsor Class
Other
Responsible Party
Sponsor Investigator
Principal Investigator

Chandan K Sen

Professor

Ohio State University

Study Sites (1)

Loading locations...

Similar Trials

Completed
Not Applicable
Calibrating Imaging Techniques to Study Blood FlowHealthy Volunteers Only
NCT00546091Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)15
Recruiting
Early Phase 1
Image-Based, In-Vivo Assessment of Tumor Hypoxia to Guide Hypoxia-Driven Adaptive Radiation TherapyHead and Neck Squamous Cell CarcinomaBrain Metastases
NCT05996432Vanderbilt-Ingram Cancer Center48
Completed
Not Applicable
on-invasive imaging of perfusion and oxygenation of the LOWer extremities in healthy volunteers by means of Multispectral Optoacoustic Tomography (LOW-MSOT)
NL-OMON38860niversitair Medisch Centrum Groningen10
Active, not recruiting
Phase 1
Multi-modality Imaging and Collection of Biospecimen Samples in Understanding Bone Marrow Changes in Patients With Acute Myeloid Leukemia Undergoing TBI and ChemotherapyAcute Myeloid LeukemiaAcute Lymphoblastic Leukemia
NCT03422731City of Hope Medical Center82
Active, not recruiting
Phase 1
Phase 2a open label study of Fovista¿ (anti-PDGF agent) administered in combination with anti-VEGF therapy in subjects previously treated or treatment-naive.Subfoveal choroidal neovascularization secondary to Age-Related Macular Degeneration (AMD)MedDRA version: 20.0Level: PTClassification code 10071129Term: Neovascular age-related macular degenerationSystem Organ Class: 10015919 - Eye disordersMedDRA version: 20.1Level: LLTClassification code 10067791Term: Wet macular degenerationSystem Organ Class: 10015919 - Eye disorders
EUCTR2015-000519-42-ITIVERIC bio, Inc.32